Nimbus Discovery Garners New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=abe8b11b-af4c-41f0-8e0c-b0a56d36a27e&Preview=1 -
Date
3/10/2011 -
Company Name
Nimbus Discovery -
Mailing Address
25 1st St. Cambridge, MA 02141 -
Company Description
Nimbus Discovery is applying advances in computer-based drug discovery to unlock fundamental biological pathways. Nimbus has already delivered selective, potent, and differentiated compounds within the first year for two disease targets, IRAK4 and ACC, which are pivotal to the progression of an aggressive subtype of non-Hodgkin’s lymphoma and obesity, respectively. -
Website
http://www.nimbusdiscovery.com -
Transaction Type
Venture Equity -
Transaction Amount
Undisclosed -
Transaction Round
Undisclosed -
Proceeds Purposes
The funds will be used to advance Nimbus’ lead programs in diffuse large B-cell lymphoma, an aggressive blood cancer, inflammatory disorders, and metabolic disease. -
M&A Terms
-
Venture Investor
Cascade Investment -
Venture Investor
Atlas Venture
